Highlights
- Dishman Carbogen Amcis reported total income of ₹69,580.00 lakh for the quarter ended June 2026.
- Profit before tax stood at a loss of ₹5,122.00 lakh, while net loss was ₹5,788.00 lakh.
- The stock declined to ₹171.44, down ₹19.22 or 10.08% from the previous close.
- The share price is below its 50-day SMA of ₹185.40, indicating weakness in the current price structure.
- Trading volume reached 2.22 million shares, while RSI 14 declined to 36.74.
- Investors should monitor quarterly losses, operating performance, price stability, trading volume and the next earnings update.
Overview
Dishman Carbogen Amcis Limited (NSE: DCAL) operates in the pharmaceutical and chemical manufacturing services space. On August 17, 2026, the stock opened at ₹176.60, moved to a high of ₹178.40 and touched a low of ₹168.42 before trading at ₹171.44. The stock declined ₹19.22, or 10.08%, from the previous close of ₹190.66, while the VWAP stood at ₹173.80. The latest decline followed the company’s June 2026 quarterly financial update, which showed a significant loss at the profit and net-profit levels. The market reaction was negative, with the stock also moving below its recent trading range and medium-term moving-average reference.
Fundamental View
For the quarter ended June 2026, Dishman Carbogen Amcis reported total income of ₹69,580.00 lakh, while profit before tax stood at a loss of ₹5,122.00 lakh and net loss was ₹5,788.00 lakh. Earnings per share was negative at ₹3.69. The reported profit before tax margin was approximately negative 7.36%, while the net loss margin was approximately negative 8.32% based on total income. The latest results highlight continued pressure at the profitability level. Future monitoring points include revenue performance, operating costs, margins, debt-related factors, business execution and the company’s ability to improve profitability across subsequent quarters.
Technical View
The stock has developed a weaker short-term price structure after the latest decline, with the price falling below the 50-day SMA of ₹185.40. The session low of ₹168.42 represents the latest downside reference, while the sharp red candle indicates substantial selling activity during the session. RSI 14 stood at 36.74, showing weakened momentum but remaining above the traditional oversold threshold. Trading volume was 2.22 million shares, considerably highlighting active participation during the decline. The price is currently positioned below the moving average, while momentum and recent price action remain subdued.
Key Technical Levels
Support is visible around ₹162.87, followed by the next support zone near ₹154.30. Resistance is positioned around ₹180.01, while the next resistance area is near ₹188.58. The 50-day SMA at ₹185.40 remains an additional technical reference between the nearby resistance areas. Price behaviour around these levels may indicate whether the recent decline begins to stabilise or develops into a broader weakening of the current structure.
Risks to Watch
- Further weakness below the recent session low of ₹168.42.
- Continued quarterly losses could weigh on the company’s financial profile.
- A sustained price position below the 50-day SMA may keep the technical structure weak.
- High trading volatility could result in wider day-to-day price movements.
- Changes in pharmaceutical outsourcing demand, operating costs and business execution could affect future results.
Summary
Dishman Carbogen Amcis operates in pharmaceutical and chemical manufacturing services, while its June 2026 quarter reported total income of ₹69,580.00 lakh alongside a profit before tax loss of ₹5,122.00 lakh and net loss of ₹5,788.00 lakh. The stock declined 10.08% in the latest session following the quarterly update and is currently below its 50-day SMA of ₹185.40. RSI at 36.74 and elevated trading volume reflect weaker momentum and active market participation. Future monitoring will focus on profitability improvement, operating performance, margins, price stability, trading activity and upcoming quarterly results.
FAQs
Q: What happened to Dishman Carbogen Amcis stock after the latest results?
A: Dishman Carbogen Amcis traded at ₹171.44 on August 17, 2026, declining ₹19.22 or 10.08% from the previous close of ₹190.66.
Q: What were Dishman Carbogen Amcis’ June 2026 quarter results?
A: Total income was ₹69,580.00 lakh, while profit before tax was a loss of ₹5,122.00 lakh and net loss stood at ₹5,788.00 lakh.
Q: What was Dishman Carbogen Amcis’ EPS in Q1 FY27?
A: Earnings per share was negative at ₹3.69 for the quarter ended June 2026.
Q: What is Dishman Carbogen Amcis’ 50-day SMA?
A: The 50-day SMA shown on the chart is ₹185.40, which is above the current traded price of ₹171.44.
Q: Which technical levels should investors monitor for Dishman Carbogen Amcis?
A: The key support zones are around ₹162.87 and ₹154.30, while resistance is visible around ₹180.01 and ₹188.58.